Cargando…
Cardiovascular Safety and Superiority of Anti-Obesity Medications
Over the past few decades, several anti-obesity medications have demonstrated an association with adverse cardiovascular outcomes, leading to their market withdrawal. This has caused researchers to investigate the cardiovascular safety of such medications in cardiovascular outcome trials. However, t...
Autores principales: | Alobaida, Muath, Alrumayh, Abdullah, Oguntade, Ayodipupo S, Al-Amodi, Faez, Bwalya, Mwango |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286099/ https://www.ncbi.nlm.nih.gov/pubmed/34285527 http://dx.doi.org/10.2147/DMSO.S311359 |
Ejemplares similares
-
Catheter ablation superiority over the pharmacological treatments in atrial fibrillation: a dedicated review
por: Alrumayh, Abdullah, et al.
Publicado: (2021) -
Rate control strategies for atrial fibrillation
por: Alobaida, Muath, et al.
Publicado: (2021) -
Imaging Protocol, Feasibility, and Reproducibility of Cardiovascular Phenotyping in a Large Tri-Ethnic Population-Based Study of Older People: The Southall and Brent Revisited (SABRE) Study
por: Al Saikhan, Lamia, et al.
Publicado: (2020) -
Corrigendum: Imaging Protocol, Feasibility, and Reproducibility of Cardiovascular Phenotyping in a Large Tri-Ethnic Population-Based Study of Older People: The Southall and Brent Revisited (SABRE) Study
por: Al Saikhan, Lamia, et al.
Publicado: (2021) -
Risk factors of heart failure among patients with hypertension attending a tertiary hospital in Ibadan, Nigeria: The RISK-HHF case-control study
por: Oguntade, Ayodipupo S., et al.
Publicado: (2021)